Sabra Healthcare REIT Inc (NASDAQ:SBRA) finished Friday with a subtraction of -$0.06 to close at $13.94, a downside of -0.43 percent. An average of 2,450,240 shares of common stock have been traded in the last five days. The last 20 days have seen an average of 3,040,500 shares traded, while the 50-day average volume stands at 2,446,038.
SBRA stock has increased by 9.42% in the last month. The company shares reached their 1-month lowest point of $12.31 on 08/30/23. With the stock rallying to its 52-week high on 09/22/23, shares of the company touched a low of $10.08 and a high of $14.32 in 52 weeks. It has reached a new high 13 times so far this year and achieved 12.15% or $1.51 in price. In spite of this, the price is down -2.65% from the 52-week high.
Valuation Metrics
Sabra Healthcare REIT Inc (SBRA) stock’s beta is 1.24. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 5.12, the price-to-book (PB) ratio at 1.09, and the price-to-cash flow ratio at 10.23.
Financial Health
Further, the company has a long term debt to equity ratio of 0.83 and a total debt to equity ratio of 0.84 for the quarter ending June 29. Its gross profit as reported stood at $140.66 million compared to revenue of $624.81 million.
Earnings Surprise
For the three-month period that ended June 29, Sabra Healthcare REIT Inc had $48.27 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $21.19 million in the quarter, while revenues of -$9.49 million were grew 20.67%. The analyst consensus anticipated Sabra Healthcare REIT Inc’s latest quarter earnings to come in at $0.1 per share, but it turned out to be $0.09, a -10.00% surprise. For the quarter, EBITDA amounted to $102.47 million. At the end of the quarter ending June 29, Sabra Healthcare REIT Inc’s stock balance sheet showed total debt was $2.42 billion. Shareholders own equity worth $231.22 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Sabra Healthcare REIT Inc (SBRA) price momentum. RSI 9-day as of the close on 29 September was 67.27%, suggesting the stock is Neutral, with historical volatility in this time frame at 25.17%.
As of today, SBRA’s price is $13.90 unch or $unch from its 5-day moving average. SBRA is currently trading +11.25% higher than its 20-day SMA and +22.82% higher than its 100-day SMA. However, the stock’s current price level is +6.33% above the SMA50 and +10.81% above the SMA200.
The stochastic %K and %D were 68.23% and 69.67%, respectively, and the average true range (ATR) was 0.32. With the 14-day stochastic at 67.80% and the average true range at 0.31, the RSI (14) stands at 66.60%. The stock has reached 0.05 on the 9-day MACD Oscillator while the 14-day reading was at 0.24.
Analyst Ratings
Jefferies upgraded Sabra Healthcare REIT Inc (NASDAQ: SBRA) to a a Buy rating in its most recent analyst report. Previously, the stock was rated as a Hold. The consensus rating for Sabra Healthcare REIT Inc (SBRA) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell SBRA, while 9 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is SBRA’s price target for the next 12 months?
Analysts predict a range of price targets between $12.50 and $15.00, with a median target of $14.00. Taking a look at these predictions, the average price target given by analysts for Sabra Healthcare REIT Inc (SBRA) stock is $13.79.
